Compare GNLX & SILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNLX | SILC |
|---|---|---|
| Founded | 2001 | 1987 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.4M | 79.8M |
| IPO Year | 2023 | 1994 |
| Metric | GNLX | SILC |
|---|---|---|
| Price | $4.32 | $14.64 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $19.75 | N/A |
| AVG Volume (30 Days) | ★ 187.8K | 13.5K |
| Earning Date | 11-05-2025 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $59,509,000.00 |
| Revenue This Year | N/A | $6.48 |
| Revenue Next Year | N/A | $14.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.99 | $12.44 |
| 52 Week High | $8.54 | $19.37 |
| Indicator | GNLX | SILC |
|---|---|---|
| Relative Strength Index (RSI) | 35.71 | 44.41 |
| Support Level | $4.37 | $14.15 |
| Resistance Level | $4.75 | $14.88 |
| Average True Range (ATR) | 0.42 | 0.51 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 8.99 | 26.54 |
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, FPGA-Based Cards, x86 Open Appliances, Bypass Switches, and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.